CVE:SBM Sirona Biochem (SBM) Stock Price, News & Analysis C$0.06 -0.01 (-7.69%) As of 03/7/2025 Add Compare Share Share Stock Analysis Stock AnalysisBuy This Stock About Sirona Biochem Stock (CVE:SBM) Get Sirona Biochem alerts:Sign Up Key Stats Today's RangeC$0.06▼C$0.0650-Day RangeC$0.06▼C$0.0652-Week RangeC$0.02▼C$0.10Volume182,010 shsAverage Volume79,592 shsMarket CapitalizationC$15.41 millionP/E RatioN/ADividend Yield1.50%Price TargetN/AConsensus RatingN/A Company Overview Sirona Biochem Corp., a cosmetic ingredient and drug discovery company, develops and sells cosmetic and pharmaceutical active ingredients in Canada and France. Its programs include cosmetic skin lightener and diabetes drug; and other projects comprise the development of an anti-aging/cell protection library, novel anti-wrinkle compound, and anti-viral program. The company was formerly known as High Rider Capital Inc. and changed its name to Sirona Biochem Corp. in May 2009. Sirona Biochem Corp. was incorporated in 2006 and is headquartered in Vancouver, Canada. Read More Receive SBM Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Sirona Biochem and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. SBM Stock News HeadlinesSirona Biochem Corp. (SBM.V) - Yahoo FinanceJune 28, 2025 | au.finance.yahoo.comSirona Biochem Launches Convertible Debenture Offering to Raise $400,000April 22, 2025 | tipranks.comRead this warning immediatelyPorter Stansberry, founder of one of the world's largest financial research firms, says he's breaking the biggest story of his 26-year career. A famous historian whose books have sold over 45 million copies in 65 languages is warning of a structural shift so large it has only one historical parallel - 1776. One Stanford economist calls it 'the biggest change ever - bigger than electricity, bigger than the steam engine.' Stansberry outlines the stocks to buy, the stocks to sell, and three money moves to position yourself on the right side of this shift.June 13 at 1:00 AM | Porter & Company (Ad)Sirona Biochem Secures Strategic Investment Agreements and New Joint Venture with Promura GmbHApril 22, 2025 | financialpost.comFSirona Biochem Showcases TFC-1326 in Stonegate Healthcare’s Landmark ReportJanuary 16, 2025 | markets.businessinsider.comUpdate: Stonegate Initiates Coverage on Sirona Biochem Corp (TSX-V:SBM)October 22, 2024 | theglobeandmail.comSirona Biochem Corp (SBM)October 2, 2024 | investing.comSirona Biochem Corp. With CEO & Chairman, Howard Verrico | September 26, 2024September 27, 2024 | msn.comSee More Headlines SBM Stock Analysis - Frequently Asked Questions How have SBM shares performed this year? Sirona Biochem's stock was trading at C$0.06 at the beginning of 2026. Since then, SBM shares have increased by 0.0% and is now trading at C$0.06. How do I buy shares of Sirona Biochem? Shares of SBM stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers. What other stocks do shareholders of Sirona Biochem own? Based on aggregate information from My MarketBeat watchlists, some other companies that Sirona Biochem investors own include Ampliphi Biosciences (APHB), Apellis Pharmaceuticals (APLS), Athersys (ATHX), Iovance Biotherapeutics (IOVA), Sorrento Therapeutics (SRNE). Industry, Sector and Symbol Stock ExchangeCVE SectorMedical Industry Biotechnology Sub-IndustryN/A Current SymbolCVE:SBM CIKN/A Webwww.sironabiochem.com Phone604-641-4466FaxN/AEmployeesN/AYear FoundedN/AProfitability EPS (Trailing Twelve Months)C($0.01) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income-C$2.67 million Net MarginsN/A Pretax MarginN/A Return on Equity-9,810.47% Return on Assets-148.11% Debt Debt-to-Equity Ratio219.21 Current Ratio0.34 Quick Ratio2.41 Sales & Book Value Annual SalesC$683.77 thousand Price / Sales22.54 Cash FlowC$0.00 per share Price / Cash Flow35.00 Book ValueC($0.01) per share Price / Book-6.00Miscellaneous Outstanding Shares256,820,000Free FloatN/AMarket CapC$15.41 million OptionableNot Optionable Beta-0.03 Options Trading Made Easy - Download NowLearn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.Get This Free Report This page (CVE:SBM) was last updated on 6/13/2026 by MarketBeat.com Staff. From Our PartnersTrump Takes Emergency Action - Plus Elon Musk's New VentureElon Musk has quietly launched a new venture - one that has nothing to do with rockets, EVs, or Neuralink. Tru...Altimetry | SponsoredCODE RED: AI Meltdown Imminent?After correctly predicting the 2008 and 2020 stock market meltdowns, I believe this AI company is about to tri...Paradigm Press | SponsoredSpaceX is chump change compared to Elon’s $20T ‘iPhone’Early Apple investors saw peak gains as high as 7,537% after the iPhone launched. Now, multiple insider source...StocksToTrade | SponsoredIs SpaceX really worth 1.78 Trillion?With SpaceX approaching a near-$2 trillion valuation, most investors are focused on the IPO itself - but analy...InvestPub | SponsoredOne hidden supplier shipped 5 billion parts to SpaceXMost investors are focused on the historic $1.75 trillion SpaceX IPO expected around June 30. But there's a le...Weiss Ratings | SponsoredTrump just signed itA recent policy development is drawing attention from income-focused investors. According to one analyst, c...Investors Alley | SponsoredStranded On The Flood Plains of HistoryThe petrodollar arrangement that Kissinger brokered in 1974 officially expired in June 2024. China has slashed...Porter & Company | SponsoredMassive Data Leak Exposes 512,000-Line Code That Could Change Society Forever"You won't believe what I discovered at 4 World Trade Center" When our financial media correspondent travel...Chaikin Analytics | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Sirona Biochem Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Share Sirona Biochem With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.